Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by bionicjoeon Jan 09, 2019 9:02am
27 Views
Post# 29204843

RE:RE:RE:RE:RE:Bloomberg interview

RE:RE:RE:RE:RE:Bloomberg interview
Hedgefundharry wrote: Agree, I’m not going anywhere, long and strong.  Would like to see some positive news on the sales side, Coke?

glta

harry


That's the only thing missing right now. I just can't see them passing on the edibles market so they'll have to address that soon if they hope to be ready with products by Oct 2019. I'm not so sure about Coke. It's more a family drink and they may not want to be tied to cannabis right now when it's still federally illegal in the States. On the other hand a multi national spirit company is already geared to the adult consumer market and would be a perfect fit. I just wish the company would stop hinting at a deal and just get one done. Same goes for Aphria.
Bullboard Posts